Table of Contents Table of Contents 1 Industry Overview 1.1 Breakthrough Therapy (BT) Designation Industry Figure Breakthrough Therapy (BT) Designation Industry Chain Structure 1.1.1 Overview 1.1.2 Development of Breakthrough Therapy (BT) Designation 1.2 Market Segment 1.2.1 Upstream Table Upstream Segment of Breakthrough Therapy (BT) Designation 1.2.2 Downstream Table Application Segment of Breakthrough Therapy (BT) Designation Table Global Breakthrough Therapy (BT) Designation Market 2016-2026, by Application, in USD Million 1.2.3 COVID-19 Impact 1.3 Cost Analysis 2 Industry Environment (PEST Analysis) 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Breakthrough Therapy (BT) Designation Market by Type 3.1 By Type 3.1.1 Oncology  Table Major Company List of Oncology  3.1.2 Infectious Diseases  Table Major Company List of Infectious Diseases  3.1.3 Rare Diseases  Table Major Company List of Rare Diseases  3.1.4 Autoimmune Diseases  Table Major Company List of Autoimmune Diseases  3.1.5 Pulmonary Diseases  Table Major Company List of Pulmonary Diseases  3.1.6 Neurological Disorders  Table Major Company List of Neurological Disorders  3.1.7 Others Table Major Company List of Others 3.2 Market Size Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Type, in USD Million Figure Global Breakthrough Therapy (BT) Designation Market Growth 2016-2020, by Type, in USD Million Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Type, in Volume Figure Global Breakthrough Therapy (BT) Designation Market Growth 2016-2020, by Type, in Volume 3.3 Market Forecast Table Global Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Type, in USD Million Table Global Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Type, in Volume 4 Major Companies List 4.1 Roche  (Company Profile, Sales Data etc.) 4.1.1 Roche  Profile Table Roche  Overview List 4.1.2 Roche  Products & Services 4.1.3 Roche  Business Operation Conditions Table Business Operation of Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.2 Abbvie  (Company Profile, Sales Data etc.) 4.2.1 Abbvie  Profile Table Abbvie  Overview List 4.2.2 Abbvie  Products & Services 4.2.3 Abbvie  Business Operation Conditions Table Business Operation of Abbvie  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.3 Novartis International AG  (Company Profile, Sales Data etc.) 4.3.1 Novartis International AG  Profile Table Novartis International AG  Overview List 4.3.2 Novartis International AG  Products & Services 4.3.3 Novartis International AG  Business Operation Conditions Table Business Operation of Novartis International AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.4 Janssen  (Company Profile, Sales Data etc.) 4.4.1 Janssen  Profile Table Janssen  Overview List 4.4.2 Janssen  Products & Services 4.4.3 Janssen  Business Operation Conditions Table Business Operation of Janssen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.5 BMS  (Company Profile, Sales Data etc.) 4.5.1 BMS  Profile Table BMS  Overview List 4.5.2 BMS  Products & Services 4.5.3 BMS  Business Operation Conditions Table Business Operation of BMS  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.6 Eli Lilly  (Company Profile, Sales Data etc.) 4.6.1 Eli Lilly  Profile Table Eli Lilly  Overview List 4.6.2 Eli Lilly  Products & Services 4.6.3 Eli Lilly  Business Operation Conditions Table Business Operation of Eli Lilly  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.7 Gilead  (Company Profile, Sales Data etc.) 4.7.1 Gilead  Profile Table Gilead  Overview List 4.7.2 Gilead  Products & Services 4.7.3 Gilead  Business Operation Conditions Table Business Operation of Gilead  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.8 Sanofi  (Company Profile, Sales Data etc.) 4.8.1 Sanofi  Profile Table Sanofi  Overview List 4.8.2 Sanofi  Products & Services 4.8.3 Sanofi  Business Operation Conditions Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.9 Regeneron  (Company Profile, Sales Data etc.) 4.9.1 Regeneron  Profile Table Regeneron  Overview List 4.9.2 Regeneron  Products & Services 4.9.3 Regeneron  Business Operation Conditions Table Business Operation of Regeneron  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.10 Acadia  (Company Profile, Sales Data etc.) 4.10.1 Acadia  Profile Table Acadia  Overview List 4.10.2 Acadia  Products & Services 4.10.3 Acadia  Business Operation Conditions Table Business Operation of Acadia  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.11 Boehringer Ingelheim  (Company Profile, Sales Data etc.) 4.11.1 Boehringer Ingelheim  Profile Table Boehringer Ingelheim  Overview List 4.11.2 Boehringer Ingelheim  Products & Services 4.11.3 Boehringer Ingelheim  Business Operation Conditions Table Business Operation of Boehringer Ingelheim  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.12 Amgen  (Company Profile, Sales Data etc.) 4.12.1 Amgen  Profile Table Amgen  Overview List 4.12.2 Amgen  Products & Services 4.12.3 Amgen  Business Operation Conditions Table Business Operation of Amgen  (Sales Revenue, Cost, Gross Margin) 4.13 AstraZeneca  (Company Profile, Sales Data etc.) 4.13.1 AstraZeneca  Profile Table AstraZeneca  Overview List 4.13.2 AstraZeneca  Products & Services 4.13.3 AstraZeneca  Business Operation Conditions Table Business Operation of AstraZeneca  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.14 GlaxoSmithKline  (Company Profile, Sales Data etc.) 4.14.1 GlaxoSmithKline  Profile Table GlaxoSmithKline  Overview List 4.14.2 GlaxoSmithKline  Products & Services 4.14.3 GlaxoSmithKline  Business Operation Conditions Table Business Operation of GlaxoSmithKline  (Sales Revenue, Cost, Gross Margin) 4.15 Vertex  (Company Profile, Sales Data etc.) 4.15.1 Vertex  Profile Table Vertex  Overview List 4.15.2 Vertex  Products & Services 4.15.3 Vertex  Business Operation Conditions Table Business Operation of Vertex  (Sales Revenue, Cost, Gross Margin) 4.16 Alexion  (Company Profile, Sales Data etc.) 4.16.1 Alexion  Profile Table Alexion  Overview List 4.16.2 Alexion  Products & Services 4.16.3 Alexion  Business Operation Conditions Table Business Operation of Alexion  (Sales Revenue, Cost, Gross Margin) 4.17 Merck  (Company Profile, Sales Data etc.) 4.17.1 Merck  Profile Table Merck  Overview List 4.17.2 Merck  Products & Services 4.17.3 Merck  Business Operation Conditions Table Business Operation of Merck  (Sales Revenue, Cost, Gross Margin) 4.18 Jazz Pharmaceuticals  (Company Profile, Sales Data etc.) 4.18.1 Jazz Pharmaceuticals  Profile Table Jazz Pharmaceuticals  Overview List 4.18.2 Jazz Pharmaceuticals  Products & Services 4.18.3 Jazz Pharmaceuticals  Business Operation Conditions Table Business Operation of Jazz Pharmaceuticals  (Sales Revenue, Cost, Gross Margin) 4.19 Exelixis  (Company Profile, Sales Data etc.) 4.19.1 Exelixis  Profile Table Exelixis  Overview List 4.19.2 Exelixis  Products & Services 4.19.3 Exelixis  Business Operation Conditions Table Business Operation of Exelixis  (Sales Revenue, Cost, Gross Margin) 4.20 Eisai  (Company Profile, Sales Data etc.) 4.20.1 Eisai  Profile Table Eisai  Overview List 4.20.2 Eisai  Products & Services 4.20.3 Eisai  Business Operation Conditions Table Business Operation of Eisai  (Sales Revenue, Cost, Gross Margin) 4.21 Takeda  (Company Profile, Sales Data etc.) 4.21.1 Takeda  Profile Table Takeda  Overview List 4.21.2 Takeda  Products & Services 4.21.3 Takeda  Business Operation Conditions Table Business Operation of Takeda  (Sales Revenue, Cost, Gross Margin) 4.22 Pfizer (Company Profile, Sales Data etc.) 4.22.1 Pfizer Profile Table Pfizer Overview List 4.22.2 Pfizer Products & Services 4.22.3 Pfizer Business Operation Conditions Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin) 5 Market Competition 5.1 Company Competition Table Global Breakthrough Therapy (BT) Designation Sales Revenue 2016-2020, by Company, in USD Million Table Global Breakthrough Therapy (BT) Designation Sales Revenue Share 2016-2020, by Company, in USD Million Figure Global Breakthrough Therapy (BT) Designation Sales Revenue Share in 2020, by Company, in USD Million Table Global Breakthrough Therapy (BT) Designation Sales Volume 2016-2020, by Company, in Volume Table Global Breakthrough Therapy (BT) Designation Sales Volume Share 2016-2020, by Company, in Volume Figure Global Breakthrough Therapy (BT) Designation Sales Volume Share in 2020, by Company, in Volume 5.2 Regional Market by Company Figure North America Breakthrough Therapy (BT) Designation Market Concentration, in 2020 Figure Europe Breakthrough Therapy (BT) Designation Market Market Concentration, in 2020 Figure Asia-Pacific Breakthrough Therapy (BT) Designation MMarket Concentration, in 2020 Figure South America Breakthrough Therapy (BT) Designation Market Concentration, in 2020 Figure Middle East & Africa Breakthrough Therapy (BT) Designation Market Concentration, in 2020 6 Demand by End Market 6.1 Demand Situation 6.1.1 Demand in Hospital  Figure Breakthrough Therapy (BT) Designation Demand in Hospital , 2016-2020, in USD Million Figure Breakthrough Therapy (BT) Designation Demand in Hospital , 2016-2020, in Volume 6.1.2 Demand in Clinic  Figure Breakthrough Therapy (BT) Designation Demand in Clinic , 2016-2020, in USD Million Figure Breakthrough Therapy (BT) Designation Demand in Clinic , 2016-2020, in Volume 6.1.3 Demand in Research Institute  Figure Breakthrough Therapy (BT) Designation Demand in Research Institute , 2016-2020, in USD Million Figure Breakthrough Therapy (BT) Designation Demand in Research Institute , 2016-2020, in Volume 6.1.4 Demand in Laboratories Figure Breakthrough Therapy (BT) Designation Demand in Laboratories, 2016-2020, in USD Million Figure Breakthrough Therapy (BT) Designation Demand in Laboratories, 2016-2020, in Volume 6.2 Regional Demand Comparison Table Regional Demand Comparison List Table Major Application in Different Regions 6.3 Demand Forecast Table Breakthrough Therapy (BT) Designation Demand Forecast 2021-2026, by Application, in USD Million Figure Breakthrough Therapy (BT) Designation Market Growth 2021-2026, by Application, in USD Million Figure Breakthrough Therapy (BT) Designation Market Share in 2026, by Application, in USD Million Table Breakthrough Therapy (BT) Designation Demand Forecast 2021-2026, by Application, in Volume Table Breakthrough Therapy (BT) Designation Market Growth 2021-2026, by Application, in Volume Table Breakthrough Therapy (BT) Designation Market Share in 2026, by Application, in Volume 6.4 Impact of the COVID-19 on the Demand 7 Region Operation 7.1 Regional Production Table Breakthrough Therapy (BT) Designation Production 2016-2020, by Region, in USD Million Table Breakthrough Therapy (BT) Designation Production 2016-2020, by Region, in Volume 7.2 Regional Market Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Region, in USD Million Table Global Breakthrough Therapy (BT) Designation Market Share 2016-2020, by Region, in USD Million Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Region, in Volume Table Global Breakthrough Therapy (BT) Designation Market Share 2016-2020, by Region, in Volume 7.3 by Region 7.3.1 North America 7.3.1.1 Overview Figure North America Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in USD Million Figure North America Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in Volume 7.3.1.2 by Country (U.S., Canada, Mexico) Table North America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million Table North America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 7.3.2 Europe 7.3.2.1 Overview Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in USD Million Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in Volume 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) Table Europe Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million Table Europe Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 7.3.3 Asia-Pacific 7.3.3.1 Overview Figure Asia-Pacific Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in USD Million Figure Asia-Pacific Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in Volume 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) Table Asia-Pacific Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million Table Asia-Pacific Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 7.3.4 South America 7.3.4.1 Overview Figure South America Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in USD Million Figure South America Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in Volume 7.3.4.2 by Country (Brazil, Argentina etc.) Table South America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million Table South America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 7.3.5 Middle East & Africa 7.3.5.1 Overview Figure Middle East & Africa Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in USD Million Figure Middle East & Africa Breakthrough Therapy (BT) Designation Market Size and Growth 2016-2020, in Volume 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) Table Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million Table Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 7.4 Regional Import & Export 7.5 Regional Forecast Table Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Region, in USD Million Table Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Region, in Volume 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change Table Price Factors List 8.1.3 Manufacturers Gross Margin Analysis 8.2 Marketing Channel Figure Marketing Channels Overview 9 Research Conclusion

List of Table List of Table 1. Table Upstream Segment of Breakthrough Therapy (BT) Designation 2. Table Application Segment of Breakthrough Therapy (BT) Designation 3. Table Global Breakthrough Therapy (BT) Designation Market 2016-2026, by Application, in USD Million 4. Table Major Company List of Infectious Diseases  5. Table Major Company List of Rare Diseases  6. Table Major Company List of Autoimmune Diseases  7. Table Major Company List of Pulmonary Diseases  8. Table Major Company List of Neurological Disorders  9. Table Major Company List of Others 10. Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Type, in USD Million 11. Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Type, in Volume 12. Table Global Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Type, in USD Million 13. Table Global Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Type, in Volume 14. Table Roche  Overview List 15. Table Business Operation of Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 16. Table Abbvie  Overview List 17. Table Business Operation of Abbvie  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 18. Table Novartis International AG  Overview List 19. Table Business Operation of Novartis International AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 20. Table Janssen  Overview List 21. Table Business Operation of Janssen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 22. Table BMS  Overview List 23. Table Business Operation of BMS  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 24. Table Eli Lilly  Overview List 25. Table Business Operation of Eli Lilly  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 26. Table Gilead  Overview List 27. Table Business Operation of Gilead  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 28. Table Sanofi  Overview List 29. Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 30. Table Regeneron  Overview List 31. Table Business Operation of Regeneron  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 32. Table Acadia  Overview List 33. Table Business Operation of Acadia  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 34. Table Boehringer Ingelheim  Overview List 35. Table Business Operation of Boehringer Ingelheim  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 36. Table Amgen  Overview List 37. Table Business Operation of Amgen  (Sales Revenue, Cost, Gross Margin) 38. Table AstraZeneca  Overview List 39. Table Business Operation of AstraZeneca  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 40. Table GlaxoSmithKline  Overview List 41. Table Business Operation of GlaxoSmithKline  (Sales Revenue, Cost, Gross Margin) 42. Table Vertex  Overview List 43. Table Business Operation of Vertex  (Sales Revenue, Cost, Gross Margin) 44. Table Alexion  Overview List 45. Table Business Operation of Alexion  (Sales Revenue, Cost, Gross Margin) 46. Table Merck  Overview List 47. Table Business Operation of Merck  (Sales Revenue, Cost, Gross Margin) 48. Table Jazz Pharmaceuticals  Overview List 49. Table Business Operation of Jazz Pharmaceuticals  (Sales Revenue, Cost, Gross Margin) 50. Table Exelixis  Overview List 51. Table Business Operation of Exelixis  (Sales Revenue, Cost, Gross Margin) 52. Table Eisai  Overview List 53. Table Business Operation of Eisai  (Sales Revenue, Cost, Gross Margin) 54. Table Takeda  Overview List 55. Table Business Operation of Takeda  (Sales Revenue, Cost, Gross Margin) 56. Table Pfizer Overview List 57. Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin) 58. Table Global Breakthrough Therapy (BT) Designation Sales Revenue 2016-2020, by Company, in USD Million 59. Table Global Breakthrough Therapy (BT) Designation Sales Revenue Share 2016-2020, by Company, in USD Million 60. Table Global Breakthrough Therapy (BT) Designation Sales Volume 2016-2020, by Company, in Volume 61. Table Global Breakthrough Therapy (BT) Designation Sales Volume Share 2016-2020, by Company, in Volume 62. Table Regional Demand Comparison List 63. Table Major Application in Different Regions 64. Table Breakthrough Therapy (BT) Designation Demand Forecast 2021-2026, by Application, in USD Million 65. Table Breakthrough Therapy (BT) Designation Demand Forecast 2021-2026, by Application, in Volume 66. Table Breakthrough Therapy (BT) Designation Market Growth 2021-2026, by Application, in Volume 67. Table Breakthrough Therapy (BT) Designation Market Share in 2026, by Application, in Volume 68. Table Breakthrough Therapy (BT) Designation Production 2016-2020, by Region, in USD Million 69. Table Breakthrough Therapy (BT) Designation Production 2016-2020, by Region, in Volume 70. Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Region, in USD Million 71. Table Global Breakthrough Therapy (BT) Designation Market Share 2016-2020, by Region, in USD Million 72. Table Global Breakthrough Therapy (BT) Designation Market 2016-2020, by Region, in Volume 73. Table Global Breakthrough Therapy (BT) Designation Market Share 2016-2020, by Region, in Volume 74. Table North America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million 75. Table North America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 76. Table Europe Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million 77. Table Europe Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 78. Table Asia-Pacific Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million 79. Table Asia-Pacific Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 80. Table South America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million 81. Table South America Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 82. Table Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in USD Million 83. Table Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2016-2020, by Country, in Volume 84. Table Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Region, in USD Million 85. Table Breakthrough Therapy (BT) Designation Market Forecast 2021-2026, by Region, in Volume 86. Table Price Factors List